Advertisement BioSpecifics Technologies raises $1.12 million in financing - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

BioSpecifics Technologies raises $1.12 million in financing

BioSpecifics Technologies has raised an aggregate amount of $1.12 million through the sale of 50,000 unregistered shares of its common stock priced at $22.50 per share.

The shares were purchased by certain private investors on August 19, 2008. The shares were sold in a company managed private investment in public equity transaction at a premium over the market price. BioSpecifics did not grant options nor pay any commissions for this transaction.